PCBCX
Price
$14.16
Change
-$0.03 (-0.21%)
Updated
Jul 2 closing price
Net Assets
491.34M
RLBCX
Price
$40.45
Change
-$0.02 (-0.05%)
Updated
Jul 2 closing price
Net Assets
287.61B
Interact to see
Advertisement

PCBCX vs RLBCX

PCBCX vs RLBCX Comparison Chart in %
View a ticker or compare two or three
VS
PCBCX vs. RLBCX commentary
Jul 06, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PCBCX is a Buy and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 288B vs. PCBCX (491M). RLBCX pays higher dividends than PCBCX: RLBCX (1.51) vs PCBCX (0.96). PCBCX was incepted earlier than RLBCX: PCBCX (21 years) vs RLBCX (24 years). PCBCX (1.68) is less costly to investors than RLBCX (0.89). RLBCX is a more actively managed with annual turnover of: 50.00 vs. PCBCX (29.00). RLBCX has a lower initial minimum investment than PCBCX: RLBCX (250) vs PCBCX (2500). PCBCX annual gain was more profitable for investors over the last year : 25.13 vs. RLBCX (12.80). PCBCX (33.76) and RLBCX (32.31) have equivalent 5 years return.
PCBCXRLBCXPCBCX / RLBCX
Total Expense Ratio1.680.89189%
Annual Report Gross Expense Ratio1.680.89189%
Fund Existence21 years24 years-
Gain YTD13.4779.110148%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets491M288B0%
Annual Yield % from dividends0.961.5164%
Returns for 1 year25.1312.80196%
Returns for 3 years52.2640.80128%
Returns for 5 years33.7632.31104%
Returns for 10 years77.6181.4695%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SEB4337.15-2.79
-0.06%
Seaboard Corp
MRVI6.04-0.11
-1.79%
Maravai LifeSciences Holdings
IRM117.16-4.74
-3.89%
Iron Mountain
DIBS4.88-0.30
-5.79%
1stdibs.com
GDTC0.95-0.06
-5.93%
CytoMed Therapeutics Limited